GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,829,000 | -0.1% | 65,000 | 0.0% | 1.48% | +9.0% |
Q1 2022 | $2,831,000 | -1.3% | 65,000 | 0.0% | 1.36% | +16.2% |
Q4 2021 | $2,867,000 | +15.4% | 65,000 | 0.0% | 1.17% | +26.6% |
Q3 2021 | $2,484,000 | -4.0% | 65,000 | 0.0% | 0.92% | +40.9% |
Q2 2021 | $2,588,000 | +20.9% | 65,000 | +8.3% | 0.66% | +14.3% |
Q1 2021 | $2,141,000 | -3.0% | 60,000 | 0.0% | 0.57% | -3.5% |
Q4 2020 | $2,208,000 | -82.1% | 60,000 | -81.7% | 0.60% | -71.3% |
Q3 2020 | $12,308,000 | -7.7% | 327,000 | 0.0% | 2.07% | +29.7% |
Q2 2020 | $13,338,000 | -2.2% | 327,000 | -9.2% | 1.60% | +6.9% |
Q1 2020 | $13,640,000 | +2802.1% | 360,000 | +3500.0% | 1.49% | +5048.3% |
Q4 2019 | $470,000 | +10.1% | 10,000 | 0.0% | 0.03% | -14.7% |
Q3 2019 | $427,000 | +6.8% | 10,000 | 0.0% | 0.03% | +3.0% |
Q2 2019 | $400,000 | -4.3% | 10,000 | 0.0% | 0.03% | +3.1% |
Q1 2019 | $418,000 | +9.4% | 10,000 | 0.0% | 0.03% | 0.0% |
Q4 2018 | $382,000 | -5.0% | 10,000 | 0.0% | 0.03% | +6.7% |
Q3 2018 | $402,000 | -0.2% | 10,000 | 0.0% | 0.03% | +11.1% |
Q2 2018 | $403,000 | +3.1% | 10,000 | 0.0% | 0.03% | 0.0% |
Q1 2018 | $391,000 | +10.1% | 10,000 | 0.0% | 0.03% | +22.7% |
Q4 2017 | $355,000 | -12.6% | 10,000 | 0.0% | 0.02% | -31.2% |
Q3 2017 | $406,000 | -5.8% | 10,000 | 0.0% | 0.03% | +10.3% |
Q2 2017 | $431,000 | +2.1% | 10,000 | 0.0% | 0.03% | +16.0% |
Q1 2017 | $422,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |